12:00 AM
 | 
Mar 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

OctaplasLG regulatory update

Octapharma submitted a BLA to FDA for octaplasLG to manage preoperative or bleeding patients who require...

Read the full 58 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >